Cargando…

SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma

Urothelial carcinoma (UC), including upper tract urothelial carcinoma (UTUC) and urinary bladder urothelial carcinoma (UBUC), is a common malignant disease in developed countries. Oncogenic metabolic lesions have been associated with UC development. Methods: Using data mining, a series of studies we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Ti-Chun, Wu, Wen-Jeng, Li, Wei-Ming, Shiao, Meng-Shin, Shiue, Yow-Ling, Li, Chien-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546005/ https://www.ncbi.nlm.nih.gov/pubmed/33052246 http://dx.doi.org/10.7150/thno.51655

Ejemplares similares

Oncometabolites and the response to radiotherapy
por: Xiang, Kexu, et al.
Publicado: (2020)

The emerging role of fumarate as an oncometabolite
por: Yang, Ming, et al.
Publicado: (2012)

Oncometabolites: tailoring our genes
por: Nowicki, Stefan, et al.
Publicado: (2015)

Kynurenine: an oncometabolite in colon cancer
por: Venkateswaran, Niranjan, et al.
Publicado: (2020)

Metabolic Rewiring and the Characterization of Oncometabolites
por: Beyoğlu, Diren, et al.
Publicado: (2021)

A chemoproteomic portrait of the oncometabolite fumarate
por: Kulkarni, Rhushikesh A., et al.
Publicado: (2019)

Oncometabolites: A new insight for oncology
por: Khatami, Fatemeh, et al.
Publicado: (2019)

Oncometabolites: Unconventional triggers of oncogenic signalling cascades
por: Sciacovelli, Marco, et al.
Publicado: (2016)

Oncometabolite induced primary cilia loss in pheochromocytoma
por: O’Toole, Samuel M, et al.
Publicado: (2018)

Accumulation of oncometabolite D-2-Hydroxyglutarate by SLC25A1 inhibition: A metabolic strategy for induction of HR-ness and radiosensitivity
por: Xiang, Kexu, et al.
Publicado: (2022)

Oncometabolite modification of Keap1 links GSTZ1 deficiency with cancer
por: Guo, Weijie, et al.
Publicado: (2019)

Oncometabolites as biomarkers in thyroid cancer: a systematic review
por: Khatami, Fatemeh, et al.
Publicado: (2019)

Clinical implications of the oncometabolite succinate in SDHx‐mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2019)

Oncometabolites suppress DNA repair by disrupting local chromatin signaling
por: Sulkowski, Parker L., et al.
Publicado: (2020)

GSTZ1‐1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone
por: Yang, Fan, et al.
Publicado: (2019)

The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis
por: Wang, Tian-Xiang, et al.
Publicado: (2019)

Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
por: Fan, Jing, et al.
Publicado: (2014)

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
por: Carbonneau, Mélissa, et al.
Publicado: (2016)

Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
por: Zhao, Yue, et al.
Publicado: (2020)

Oncometabolites—A Link between Cancer Cells and Tumor Microenvironment
por: Baryła, Maksymilian, et al.
Publicado: (2022)

Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
por: Nadhan, Revathy, et al.
Publicado: (2023)

mTORC1-driven accumulation of the oncometabolite fumarate as a potential critical step in renal cancer progression
por: Drusian, Luca, et al.
Publicado: (2018)

The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites
por: Hariharan, Vivek A., et al.
Publicado: (2017)

Another small molecule in the oncometabolite mix: L-2-Hydroxyglutarate in kidney cancer
por: Shim, Eun-Hee, et al.
Publicado: (2015)

Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents
por: Corrado, Mauro, et al.
Publicado: (2016)

Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change
por: Zhou, Zhengqiu, et al.
Publicado: (2018)

Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite
por: Berger, Raffaela S., et al.
Publicado: (2021)

Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer
por: Godel, Martina, et al.
Publicado: (2021)

Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification
por: Fu, Yidian, et al.
Publicado: (2022)

Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma
por: Wu, Wen-Ren, et al.
Publicado: (2020)

Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate and promotes histone methylation
por: Fan, Jing, et al.
Publicado: (2014)

The Emerging Role of D-2-Hydroxyglutarate as an Oncometabolite in Hematolymphoid and Central Nervous System Neoplasms
por: Rakheja, Dinesh, et al.
Publicado: (2013)

From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
por: Di Gregorio, Emanuela, et al.
Publicado: (2021)

The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo
por: Suijker, Johnny, et al.
Publicado: (2015)

A Systems Approach to Predict Oncometabolites via Context-Specific Genome-Scale Metabolic Networks
por: Nam, Hojung, et al.
Publicado: (2014)

Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases
por: Evans, Brad, et al.
Publicado: (2015)

The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation
por: Jacobs, Benedikt, et al.
Publicado: (2020)

Imaging 2-hydroxyglutarate and other brain oncometabolites pertinent to critical genomic alterations in brain tumors
por: Thomas, Teena, et al.
Publicado: (2023)

GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma
por: Fang, Zhiqing, et al.
Publicado: (2022)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
por: Mu, Luyan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r6rit1krjpu4m2cbufr70k9qtg